Stephen K Gruschkus
Overview
Explore the profile of Stephen K Gruschkus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Virarkar M, Gruschkus S, Ravizzini G, Vulasala S, Javadi S, Bhosale P
Pol J Radiol
. 2024 May;
89:e196-e203.
PMID: 38783912
Purpose: The primary objective of this study was to evaluate the discriminatory utility of magnetic resonance imaging (MRI), F-fluciclovine positron emission tomography (PET), maximum standardized uptake value (SUV), prostate-specific antigen...
2.
Mustafayev F, Shukla M, Lanier A, Milton D, Gutierrez A, Gruschkus S, et al.
Cancer
. 2023 Dec;
130(9):1600-1608.
PMID: 38100492
Background: Breast cancer (BC) with germline BRCA1/2 mutations and their association with triple-negative BC has been thoroughly investigated. However, some carriers of BRCA1/2 mutations have human epidermal growth factor receptor...
3.
El Hussein S, Medeiros L, Gruschkus S, Wei P, Schlette E, Fang H, et al.
Virchows Arch
. 2023 Mar;
482(6):1011-1019.
PMID: 36864257
Immune checkpoint inhibitors (PD-1 inhibitors) have shown clinical activity in Richter transformation-diffuse large B-cell lymphoma variant (RT-DLBCL), thus providing for a novel therapeutic approach. The study group consists of 64...
4.
Pokhylevych H, Khose S, Amer A, Alhasan H, Kaya D, Johnson R, et al.
J Comput Assist Tomogr
. 2023 Jan;
47(1):136-143.
PMID: 36598462
Background And Purpose: Tectal gliomas (TGs) are rare tumors that involve critical locations in the brainstem, including the superior and inferior colliculi and the Sylvian aqueduct. The rarity of these...
5.
Pokhylevych H, Khose S, Gule-Monroe M, Chen M, Fuller G, Gruschkus S, et al.
J Comput Assist Tomogr
. 2022 Sep;
47(1):115-120.
PMID: 36112052
Background And Purpose: Brain tumors are the most common cause of cancer-related deaths among the pediatric population. Among these, pediatric glioblastomas (GBMs) comprise 2.9% of all central nervous system tumors...
6.
Daher M, Varghese J, Gruschkus S, Jimenez C, Waguespack S, Bedrose S, et al.
J Clin Endocrinol Metab
. 2022 Jan;
107(5):1239-1246.
PMID: 35092681
Context: Reporting temporal trends in adrenocortical carcinoma (ACC) helps guide management strategies. Objective: This work aimed to report the trends in disease burden and clinical outcomes over time that cannot...
7.
Ballhausen A, Urias E, Gruschkus S, Williams M, Glover M, Qin Y, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34209210
In uveal melanoma (UM), gene expression profiling (GEP) is commonly used to classify metastatic risk into three groups (Class 1A, 1B, and 2). Class 1A patients have a lower metastatic...
8.
McLemore L, Albarracin C, Gruschkus S, Bassett Jr R, Wu Y, Dhamne S, et al.
Breast Cancer Res Treat
. 2021 Apr;
187(1):95-104.
PMID: 33813685
Purpose: HER2 overexpression and gene amplification are routinely tested by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH), respectively. In addition, HER2 mRNA expression is also tested by the Oncotype...
9.
Pelster M, Gruschkus S, Bassett R, Gombos D, Shephard M, Posada L, et al.
J Clin Oncol
. 2020 Oct;
39(6):599-607.
PMID: 33125309
Purpose: Metastatic uveal melanoma has poor overall survival (OS) and no approved systemic therapy options. Studies of single-agent immunotherapy regimens have shown minimal benefit. There is the potential for improved...
10.
Nagarajan P, El-Hadad C, Gruschkus S, Ning J, Hudgens C, Sagiv O, et al.
Invest Ophthalmol Vis Sci
. 2019 May;
60(6):2388-2398.
PMID: 31141610
Purpose: Conjunctival squamous cell carcinoma (SCC), a type of ocular surface neoplasia, is primarily treated by surgical resection and topical immuno- or chemotherapy. Metastatic disease may be treated with systemic...